21.11.2023 - Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapiesPRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) - Certara, Inc. (Nasdaq: CERT), a global leader in .
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
LEXISNEXIS® REED TECH EXPANDS PORTFOLIO TO OFFER ELECTRONIC COMMON TECHNICAL DOCUMENT SUBMISSION PUBLISHING SERVICES streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ LexisNexis Legal & Professional today announced, that LexisNexis Reed Tech, provider of data management & analytic solutions for the life.
The US Food and Drug Administration (FDA) has proven time and time again that they are incapable of properly regulating the pharmaceutical industry. In the latest Pfizer drug approval, the FDA [.]